ライフサイエンスコーパス: standardized mortality ratio

1 mpared with the general population using the standardized mortality ratio.

2 the ICU scoring system used to calculate the standardized mortality ratio.

3 and both a high absolute mortality and high standardized mortality ratio.

4 patients when using the customized hospital standardized mortality ratio.

5 specially when using the customized hospital standardized mortality ratio.

6 or patients' severity and the ICU's baseline standardized mortality ratio.

7 lity using the Kaplan-Meier method and using standardized mortality ratios.

8 e Poisson regression models and by comparing standardized mortality ratios.

9 tatistic (where p>.05 suggests good fit) and standardized mortality ratios.

10 Quality-of-care tests were performed using standardized mortality ratios.

11 e the variability in subarachnoid hemorrhage standardized mortality ratios.

12 zed morbidity ratios were more variable than standardized mortality ratios.

13 oved model accuracy but had little impact on standardized mortality ratios.

14 but did not substantially change unit-level standardized mortality ratios.

15 I, 0.86-1.03) during years 1991-1995 to 29% (standardized mortality ratio 0.53; 95% CI, 0.50-0.57) du

16 .8%-5.0%; p = 0.009), decreasing from 46.9% (standardized mortality ratio 0.94; 95% CI, 0.86-1.03) du

17 superior to that of the customized hospital standardized mortality ratio (0.85 and 0.11 vs. 0.77 and

18 not indicate any excess mortality (all-cause standardized mortality ratios = 0.69 and 0.64, respectiv

19 ects exposed and nonexposed to formaldehyde (standardized mortality ratios = 0.91 and 0.78, respectiv

20 that in the population of England and Wales (standardized mortality ratio, 0.46; 95% CI, 0.42, 0.51).

21 nificantly overestimated hospital mortality (standardized mortality ratio, 0.73 [confidence interval,

22 mple that was based on U.S. population data (standardized mortality ratio, 0.98 [CI, 0.44 to 2.2]; P

23 r risk of homicide, suicide, and poisonings (standardized mortality ratios, 0.31-0.68), but higher ri

24 y than expected from the general population (standardized mortality ratio: 0.67; 95% CI: 0.55 to 0.78

25 tanding, mortality: 2.1% vs 2.8%, p < 0.001; standardized mortality ratio: 0.77 [0.73-0.82] vs 0.99 [

26 models, respectively), and good calibration (standardized mortality ratio: 0.99, 0.99, and 1.00; Hosm

27 on of actual vs. expected mortality, overall standardized mortality ratio (1.018; 95% confidence inte

28 t (observed mortality = predicted mortality; standardized mortality ratio = 1.000) and repeated with

29 ce interval (CI) 1.56-2.55) and lung cancer (standardized mortality ratio = 1.29, 95% CI 1.01-1.61).

30 of 21.7%; the observed mortality was 36.2% (standardized mortality ratio = 1.67).

31 rval (CI): 2.30, 5.56) and in the US cohort (standardized mortality ratio = 1.91, 95% CI: 1.02, 3.27)

32 handgun was greater than expected for women (standardized mortality ratio, 1.09), and the entire incr

33 t event-free survival for 24 months (pEFS24; standardized mortality ratio, 1.27; P < .001).

34 xpected survival for the general population (standardized mortality ratio, 1.34; 95% CI, 1.003-1.76;

35 oup did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidenc

36 al population (78%; 95% CI, 76 to 80; v 87%; standardized mortality ratio, 1.75; P < .001).

37 xpected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidenc

38 the general population of England and Wales (standardized mortality ratio, 11.65; 95% confidence inte

39 the excess risk among women in this cohort (standardized mortality ratio, 15.50) remained greater th

40 ess mortality from silicosis/pneumoconioses (standardized mortality ratio = 18.2, 95% confidence inte

41 the risk of completed suicide is increased (standardized mortality ratio 2-3.5); although the causes

42 or nonmalignant respiratory diseases (NMRD) (standardized mortality ratio = 2.01, 95% confidence inte

43 ignificantly elevated at 15 years after HCT (standardized mortality ratio = 2.2).

44 in the two groups (22.3% vs 20.2%; p = 0.40; standardized mortality ratio, 2.5 [2.1-3.0] vs 2.3 [1.9-

45 aled nitric oxide; 25.7% vs 7.9%; p < 0.001; standardized mortality ratio, 2.6 [2.3-3.1] vs 1.1 [1.0-

46 cidents were observed in the Vietnam cohort (standardized mortality ratio = 3.67, 95% confidence inte

47 15.50) remained greater than that among men (standardized mortality ratio, 3.23).

48 times higher than in the general population (standardized mortality ratio, 3.92; 95% confidence inter

49 rdiac death was 4-fold higher than expected (standardized mortality ratio, 4.2; 95% CI, 2.9-5.8).

50 cide by any method among handgun purchasers (standardized mortality ratio, 4.31) was attributable ent

51 Pneumonia (standardized mortality ratio 6.6, 95% confidence inciden

52 ts, falls, fires, and, especially, drowning (standardized mortality ratio=6.22).

53 to an excess risk of suicide with a firearm (standardized mortality ratio, 7.12).

54 The standardized mortality ratio (95% CI) was 4.97 (3.72-6.6

55 Standardized mortality ratios, absolute excess risks, an

56 As a result of changing mortality risk, the standardized mortality ratios across the 16 pediatric IC

57 Standardized mortality ratios adjusted for severity-of-i

58 Standardized mortality ratios also showed excess mortali

59 andom slope hierarchical model, variation in standardized mortality ratio among intensive care units

60 ive care units varied from 0.62 to 1.27; the standardized mortality ratio and 95% confidence interval

61 The hospital standardized mortality ratio and Simplified Acute Physio

62 ich can be used to make inferences about the standardized mortality ratio and the standardized incide

63 mortality based on 95% interval estimates of standardized mortality ratios and (2) differences in ris

64 Standardized mortality ratios and 95% confidence interva

65 Similar patterns were observed for both standardized mortality ratios and absolute excess risks

66 Standardized mortality ratios and absolute excess risks

67 We also compared hospitals' standardized mortality ratios and classification of hosp

68 Standardized mortality ratios and relative risks were ca

69 hierarchical regression to calculate 30-day standardized mortality ratios and risk-standardized mort

70 on administrative data (customized hospital standardized mortality ratio) and a model based on clini

71 Mortality rates, standardized mortality ratios, and 95% confidence interv

72 with mortality rates for White US men using standardized mortality ratios, and the death rates for m

73 2.20; at six years, 2.01) but low among men (standardized mortality ratio at one year, 0.84; at six y

74 ide with a firearm was elevated among women (standardized mortality ratio at one year, 2.20; at six y

75 chanical ventilation had the most discordant standardized mortality ratios between the two predictive

76 Intensive care unit standardized mortality ratios calculated with MPM0-III a

77 Comparing institutions based on standardized mortality ratios can be unfavorable for tho

78 port crude and standardised mortality rates, standardized mortality ratios comparing mortality experi

79 Standardized mortality ratios comparing the Crit-Line an

80 The VA ICU standardized mortality ratio correlates with the Nationa

81 days in 1994-96 to 2.4 per 1,000 in 2003-06; standardized mortality ratio decreased from 0.33 to 0.27

82 s, and how case-mix adjustment might explain standardized mortality ratio differences.

83 ter having a widely dispersed and multimodal standardized mortality ratio distribution.

84 The standardized mortality ratios divided observed deaths by

85 Two ICUs had standardized mortality ratios exceeding 1.75 using Natio

86 The standardized mortality ratio for all causes of death was

87 During 1998-2008, the standardized mortality ratio for CRC in individuals with

88 The standardized mortality ratio for ischaemic heart disease

89 For white miners, the standardized mortality ratio for lung cancer compared wi

90 The standardized mortality ratio for patients with recurrent

91 The standardized mortality ratio for suicide during pregnanc

92 ted World Health Organization suicide rates (Standardized Mortality Ratio for suicide: SMR 12.63-15.6

93 However, although the standardized mortality ratio for the entire cohort was h

94 Among the various subgroups, the standardized mortality ratio for the patients on dialysi

95 The standardized mortality ratio for the Quebec cohort as co

96 The original standardized mortality ratio for the silica-lung cancer

97 The overall standardized mortality ratio for those with definite or

98 For all cancers combined, the standardized mortality ratios for all cardiac diseases c

99 Standardized mortality ratios for all-cause mortality in

100 Standardized mortality ratios for all-cause mortality we

101 Estimated 15-year survival and standardized mortality ratios for deaths from nonneoplas

102 We assessed standardized mortality ratios for each ICU using data fo

103 Standardized mortality ratios for each ICU were calculat

104 We calculated standardized mortality ratios for each trial from observ

105 Standardized mortality ratios for kidney disease were co

106 eas were excessive, especially among blacks (standardized mortality ratios for men and women in Harle

107 compared with age-adjusted and race-adjusted standardized mortality ratios for women, which were calc

108 djusted mortality was noted by a decrease of standardized mortality ratio from 10.0 (95% confidence i

109 There were modest changes in an ICU's standardized mortality ratio grouping (< 1.00, not signi

110 These standardized mortality ratios have not declined substant

111 1.17 (95%CI [0.85, 1.62]), and the weighted standardized mortality ratio in cohort studies was 98 (9

112 Score II outperforms the customized hospital standardized mortality ratio in the Dutch intensive care

113 se who were alive at 20 years follow-up, the standardized mortality ratio in the subsequent years rem

114 s had influence on the intensive care units' standardized mortality ratios in both models, but the cu

115 Age and sex standardized mortality ratios measured the associations

116 ost similar to that of whites and the lowest standardized mortality ratio (men, 1.18; women, 1.08).

117 whites were studied, Detroit had the highest standardized mortality ratios (men, 2.01; women, 1.90).

118 ease (28%) and cancer (28%), with respective standardized mortality ratios nearly six-fold (5.81; 95%

119 Standardized mortality ratio (observed/expected deaths)

120 as calculated to estimate the reliability of standardized mortality ratios obtained using the three r

121 7331 (13.2%) vs. 7456 predicted, yielding a standardized mortality ratio of 0.983, 95% CI (0.963-1.0

122 e confounding by smoking, led to an adjusted standardized mortality ratio of 1.43 (95% Monte Carlo li

123 olamban R14del mutation carriers, we found a standardized mortality ratio of 1.7 (95% confidence inte

124 nity-based cohort (p< 0.001), resulting in a standardized mortality ratio of 3.49 (95% CI, 2.42-4.85)

125 first 10 years of follow-up, resulting in a standardized mortality ratio of 7.7 (95% CI=3.7-14.2).

126 ng a conditional approach and expressed as a standardized mortality ratio of observed-to-expected dea

127 Standardized mortality ratio of the intensive care units

128 ortality than the reference population, with standardized mortality ratios of 1.5 to 2.5.

129 an did women in the general population, with standardized mortality ratios of 2.15 (ages 40-49 years)

130 agreed on the significance and direction of standardized mortality ratio only 45% of the time.

131 demographic distribution would increase the standardized mortality ratio only modestly to 54 for wom

132 for each unit using a hierarchical logistic (standardized mortality ratio) or linear (OMELOS) regress

133 PM0-III identifying 33 of 135 as significant standardized mortality ratio outliers and the subgroup m

134 nal Surgical Quality Improvement Performance standardized mortality ratio (r2 = .74).

135 s relative to men in the general population; standardized mortality ratios ranged from 2.56 (ages 30-

136 Standardized mortality ratios relative to the US populat

137 Mortality estimates (eg, standardized mortality ratios, relative risks, hazard ra

138 Four ICUs had standardized mortality ratios significantly less than 1.

139 atistic (range, 10.6-15.3; p > or = .05) and standardized mortality ratio (SMR) (range, 0.93 [95% con

140 increased brain cancer in the entire cohort (standardized mortality ratio (SMR) = 0.9, 95% confidence

141 terans was not different from that expected (standardized mortality ratio (SMR) = 1.0).

142 All cancers combined (standardized mortality ratio (SMR) = 1.0, 95% confidence

143 fic mortality was elevated for mesothelioma (standardized mortality ratio (SMR) = 2.85, 95% confidenc

144 ased risk of mortality from liver cirrhosis (standardized mortality ratio (SMR) = 8.4, 95% CI 3.1-18.

145 ratio assumption is established between the standardized mortality ratio (SMR) and the life expectan

146 pared to patients without this exposure; and standardized mortality ratio (SMR) for suicide post-surg

147 The standardized mortality ratio (SMR) was 0.90 for all caus

148 A center-level standardized mortality ratio (SMR) was constructed (rati

149 ected mortality in the general population, a standardized mortality ratio (SMR) was used.

150 comparison with the general population, the standardized mortality ratio (SMR), adjusted for age and

151 ported a standardized incidence ratio (SIR), standardized mortality ratio (SMR), or data on expected

152 ith the person-years method to determine the standardized mortality ratio (SMR).

153 nit (ICU) length of stay, ICU mortality, and standardized mortality ratio (SMR).

154 HL had worse-than-expected OS as measured by standardized mortality ratio (SMR; SMR for CLL, 2.6; 95%

155 ta, we simulated report cards and calculated standardized mortality ratios (SMR) for kidney transplan

156 Kaplan-Meier survival estimates, standardized mortality ratios (SMR), and standard incide

157 at a 13-fold increased risk for late death (standardized mortality ratio [SMR] = 13.0) when compared

158 ients with cancers of the lung and bronchus (standardized mortality ratio [SMR] = 5.74; 95% CI, 5.30

159 The expected number of deaths was 87 (standardized mortality ratio [SMR]), 1.9; 95% confidence

160 ortality ratio method (main outcome measure, standardized mortality ratio [SMR]).

161 the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25).

162 sk of BC mortality was also greater for men (standardized mortality ratio [SMR], 1.32 [95% CI, 1.18-1

163 increased compared with expected mortality (standardized mortality ratio [SMR], 2.6 [95% CI, 1.8-3.7

164 tality attributable to subsequent neoplasms (standardized mortality ratios [SMR], 15.2; 95% CI, 13.9

165 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) (observed/expected

166 Standardized mortality ratios (SMRs) and 95% confidence

167 ional reference rates were used to calculate standardized mortality ratios (SMRs) and 95% confidence

168 Comparative standardized mortality ratios (SMRs) and causes of death

169 Standardized mortality ratios (SMRs) and Cox regression

170 e analysis and assessed mortality risk using standardized mortality ratios (SMRs) and marginal struct

171 registries in New York City, they calculated standardized mortality ratios (SMRs) and relative risks.

172 Standardized mortality ratios (SMRs) and standardized in

173 orth Carolina and Iowa, the authors computed standardized mortality ratios (SMRs) comparing deaths fr

174 Standardized mortality ratios (SMRs) for CVD and absolut

175 Standardized mortality ratios (SMRs) for non-diabetes-re

176 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) of ischemic heart d

177 Standardized mortality ratios (SMRs) reported by Medicar

178 Standardized mortality ratios (SMRs) were calculated for

179 Standardized mortality ratios (SMRs) were calculated for

180 Standardized mortality ratios (SMRs) were calculated for

181 Standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) were calculated for

182 Age and sex standardized mortality ratios (SMRs) were calculated usi

183 Standardized mortality ratios (SMRs) were calculated, ba

184 Significantly increased standardized mortality ratios (SMRs) were found for all

185 Standardized mortality ratios (SMRs) were used to assess

186 l were compared using the log-rank test, and standardized mortality ratios (SMRs) with expected survi

187 both U.S. Census data and death record data, standardized mortality ratios (SMRs), relative SMRs (rSM

188 ed with that of the general population using standardized mortality ratios (SMRs).

189 ge, sex, calendar date, and country to yield standardized mortality ratios (SMRs).

190 as standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs).

191 where Antofagasta is located, and calculated standardized mortality ratios (SMRs).

192 rison and mortality records, they calculated standardized mortality ratios (SMRs).

193 re younger than 75 years had higher coronary-standardized mortality ratios than men; for example, amo

194 including the two largest centers) had lower standardized mortality ratios than might be expected due

195 The standardized mortality ratio (the ratio of the number of

196 zing the effect on the intensive care units' standardized mortality ratios.The area under the receive

197 cause of death with a consistently elevated standardized mortality ratio throughout follow-up.

198 rity-adjusted mortality measures such as the standardized mortality ratio to benchmark their performa

199 We estimated a standardized mortality ratio to compare mortality in our

200 We calculated standardized mortality ratios to compare the causes of d

201 We used standardized mortality ratios to compare the groups of v

202 n of HAART, which demonstrated an increasing standardized mortality ratio trend after 1996.

203 Intensive care unit standardized mortality ratios, using the subgroup models

204 Standardized mortality ratios utilizing national US data

205 The standardized mortality ratio varied by duration of illne

206 Overall standardized mortality ratio was 0.89 using Acute Physio

207 Standardized mortality ratio was 1.16 (95% CI, 0.92 to 1

208 as 88.4% at 10 years after diagnosis and the standardized mortality ratio was 1.56 (95% confidence in

209 The lung cancer standardized mortality ratio was 1.60 (95% confidence in

210 For male patients, the age-adjusted standardized mortality ratio was 1.66; for females, it w

211 low-up of 6.27 years (141 liver deaths); the standardized mortality ratio was 2.85.

212 One-year age-standardized mortality ratio was 21-fold higher than exp

213 For American Indian miners, the lung cancer standardized mortality ratio was 3.27 (95% confidence in

214 The standardized mortality ratio was 4.37 (95% CI=2.4-7.3) f

215 The standardized mortality ratio was 4.83 (95% CI=2.91-8.01)

216 The standardized mortality ratio was high for these causes i

217 Standardized mortality ratio was not associated with OME

218 Evaluation of ICU performance using standardized mortality ratio was only modestly sensitive

219 No standardized mortality ratio was significantly elevated

220 cases with predictions in both systems, the standardized mortality ratio was similar (1.04 for VA IC

221 quality outliers were defined as ICUs whose standardized mortality ratio was statistically different

222 95% confidence interval: 0.67, 1.84) for the standardized-mortality-ratio weighted to 10.77 (95% conf

223 weights), another in the treated population (standardized-mortality-ratio weights).

224 ceiver operator characteristic curve and the standardized mortality ratio were 0.92 (confidence inter

225 The adjusted standardized mortality ratios were 0.44 (95 percent conf

226 Standardized mortality ratios were 12.2 (95% confidence

227 The standardized mortality ratios were 5.86 for AN, 1.93 for

228 Cause-specific standardized mortality ratios were 56 for cancer, 37 for

229 Standardized mortality ratios were 7.28 (95% CI: 6.50, 8

230 -adjusted rates of in-hospital mortality and standardized mortality ratios were calculated for four t

231 and cause-specific (cardiac disease, cancer) standardized mortality ratios were calculated.

232 Standardized mortality ratios were elevated for all caus

233 ng disorder not otherwise specified; suicide standardized mortality ratios were elevated for bulimia

234 The early standardized mortality ratios were high and decreased th

235 After adjustment for patient differences, standardized mortality ratios were significantly better

236 All-cause standardized mortality ratios were significantly elevate

237 Posttransplant survival and center's standardized mortality ratios were then calculated and c